Improvement of Clopidogrel Hypo-Responsiveness by Cilostazol Addition to the Dual Antiplatelet Therapy in PCI Patients Carrying CYP2C19 Gene Polymorphism

被引：0
|
作者：
Tanigawa, Takashi [1 ]
Nakata, Tomoyuki [1 ]
Ito, Masaaki [1 ]
Nishikawa, Masakatsu [1 ]
机构：
[1] Mie Univ Hosp, Tsu, Mie, Japan
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Antiplatelet drugs; Platelet receptor blockers; Intervention;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A14257
引用
收藏
页数：2
相关论文
共 50 条
  • [41] VARIABILITY IN RESPONSE: PATTERNS IN PRESCRIBING ANTIPLATELET THERAPY AFTER CYP2C19 GENOTYPING AMONG PATIENTS WITH ACS AND PCI
    Desai, Nihar
    Canestaro, Will
    Chaplin, Donald
    Martell, Lori
    Matlin, Olga
    Kyrychenko, Pavlo
    Brennan, Troyen
    Choudhry, Niteesh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E160 - E160
  • [42] Relationship of CYP2C19*2 and CYP2C19*3 Gene Polymorphism with Clopidogrel Response Variability and Recurrent Cardiovascular Events in Chinese Patients Undergoing Percutaneous Coronary Intervention
    Liu, Yamin
    Liu, Naifeng
    Li, Weilan
    Shao, Hua
    Zhi, Hong
    Li, Jie
    PHARMACOLOGY, 2013, 91 (3-4) : 165 - 172
  • [43] VARIABILITY IN RESPONSE: PATTERNS IN PRESCRIBING ANTIPLATELET THERAPY AFTER CYP2C19 GENOTYPING AMONG PATIENTS WITH ACS AND PCI
    Desai, Nihar
    Canestaro, William
    Chaplin, Donald
    Martell, Lori
    Matlin, Olga S.
    Kyrychenko, Pavlo
    Brennan, Troyen A.
    Choudhry, Niteesh K.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 : S237 - S237
  • [44] Effects of individualized antiplatelet therapy based on CYP2C19 genotype and platelet function on the prognosis of patients after PCI
    Zhang, M.
    Wang, J-R
    Zhang, Y.
    Zhang, P.
    Ren, M-Y
    Jia, X-M
    Ma, L-P
    Gao, M.
    Hou, Y-L
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (20) : 10753 - 10768
  • [45] THE ANTIPLATELET EFFECT OF CLOPIDOGREL IS WEAKER FOR JAPANESE PATIENTS PROBABLY DUE TO FREQUENT CYP2C19 POLYMORPHISMS
    Kita, T.
    Jinnai, T.
    Makiyama, T.
    Horiuchi, H.
    Kimura, T.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [46] Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles
    Jing Lin
    Zhao Han
    Chun Wang
    Xingyang Yi
    Zhenxiao Chai
    Qiang Zhou
    Ruyue Huang
    European Journal of Clinical Pharmacology, 2018, 74 : 1131 - 1140
  • [47] Association of CYP2C19 Polymorphism with Clopidogrel Resistance in Patients with Acute Coronary Syndrome in China
    Su, Qiang
    Li, Jian
    Tang, Zhili
    Yang, Siyun
    Xing, Guoqiang
    Liu, Tao
    Peng, Hong
    MEDICAL SCIENCE MONITOR, 2019, 25 : 7138 - 7148
  • [48] Effects of CYP2C19 polymorphism on clopidogrel treatment in patients with carotid stenosis treated with stent
    Moniche, F.
    Gonzalez-Marcos, J. R.
    Gutierrez, I.
    Garcia-Lozano, J. R.
    Torrecillas, F.
    Cayuela, A.
    Mayol, A.
    Gonzalez, A.
    CEREBROVASCULAR DISEASES, 2013, 35 : 844 - 844
  • [49] Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles
    Lin, Jing
    Han, Zhao
    Wang, Chun
    Yi, Xingyang
    Chai, Zhenxiao
    Zhou, Qiang
    Huang, Ruyue
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (09) : 1131 - 1140
  • [50] Correlation between CYP2C19 gene polymorphism and clinical efficacy of clopidogrel in patients with coronary artery heart disease
    Sun, Kui
    Zhang, Pei-Pei
    Gong, Ya-Nan
    Wang, Xiang-Bo
    Meng, Yan
    Zhang, Feng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (07): : 5290 - 5296
12345